Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Title
Drug target selection and validation / Marcus T. Scotti, Carolina L. Bellera, editors.
ISBN
9783030958954 (electronic bk.)
3030958957 (electronic bk.)
9783030958947
3030958949
Published
Cham : Springer, [2022]
Copyright
©2022
Language
English
Description
1 online resource : illustrations (chiefly color).
Other Standard Identifiers
10.1007/978-3-030-95895-4 doi
Call Number
RM301.25
Dewey Decimal Classification
615.1/90113
Summary
The first book in the newly created book series, Computer-Aided Drug Discovery and Design, focuses on the computational aspects of early drug discovery, drug target identification, and validation. It revises current classical paradigms in target and phenotypic-based drug design with still ingrained approximations and concepts and discusses the research in the new network approach concept that include kinetic selectivity and metabolic analysis. Many often-overlooked approximations and concepts in drug discovery are fully covered. Drug Target Selection and Validation includes both introductory sections and research-based sections to be of use to both students and research scientists in drug discovery, design, kinetics and metabolic analysis. Pharmaceutical scientists, pharmaceutics, drug developers, pharmacologists, biomedical researchers in computer science, medicinal chemists, and precision medicine developers benefit from the information provided. The book concludes with a chapter on chemical and structural databases.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed May 31, 2022).
Series
Computer-aided drug discovery and design.
Available in Other Form
Print version: 9783030958947
Drug discovery paradigms: target-based drug discovery
Drug discovery paradigms: phenotypic-based drug discovery
Target Identification Approaches in Drug Discovery
Introduction to target validation
Structure-based binding pocket detection and druggability assessment
Network-Based Target Identification
The Current State of Precision Medicine and Targeted-Cancer Therapies Where are We?
Metabolic Control Analysis for drug target selection against human diseases
Progress on open chemoinformatic tools for drug discovery.
